C9143 HCPCS Level II code: Cocaine hydrochloride nasal solution (numbrino), 1 mg
C9143 is the HCPCS code for “Cocaine hydrochloride nasal solution (numbrino), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9143Cocaine hydrochloride nasal solution (numbrino), 1 mg
Short description: Cocaine hcl nasal (numbrino)
HCPCS · United States
Medicare details
The indicators CMS publishes with C9143 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Jan 1, 2023
Where C9143 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9143Cocaine hydrochloride nasal solution (numbrino), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9143 mean?
C9143 is the HCPCS code for “Cocaine hydrochloride nasal solution (numbrino), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9143?
CMS lists C9143’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9143
All C codesC9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgC9144Injection, bupivacaine (posimir), 1 mgC9145Injection, aprepitant, (aponvie), 1 mgC9146Injection, mirvetuximab soravtansine-gynx, 1 mgC9147Injection, tremelimumab-actl, 1 mgC9148Injection, teclistamab-cqyv, 0.5 mgC9149Injection, teplizumab-mzwv, 5 mcg